Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Monday. The brokerage issued a hold rating on the stock.

Milestone Scientific Stock Performance

Shares of MLSS opened at $0.95 on Monday. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10. The stock has a 50-day moving average price of $0.97 and a 200 day moving average price of $0.79. The company has a market capitalization of $73.37 million, a P/E ratio of -9.50 and a beta of 1.08.

Milestone Scientific (NYSE:MLSS) last posted its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The company had revenue of $1.85 million during the quarter. Milestone Scientific had a negative net margin of 54.87% and a negative return on equity of 60.78%.

Insider Activity at Milestone Scientific

In other news, Director Leonard Osser sold 141,913 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total transaction of $134,817.35. Following the sale, the director now directly owns 4,602,506 shares in the company, valued at approximately $4,372,380.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 24.75% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.